HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mixed bacterial infection model of sepsis in rabbits and its application to evaluate superantigen-adsorbing device.

AbstractBACKGROUND:
Superantigens are suspected to be the potent and lethal pathogens of gram-positive sepsis, and a new therapy that targeted to superantigens are required.
METHODS:
A mixed infection model was developed in rabbits by the cecal ligation and puncture associated with the intraperitoneal injection of Staphylococcus aureus, which produces toxic shock syndrome toxin 1 (TSST-1). Animals were also hemoperfused with a superantigen-adsorbing device (SAAD), or a control column.
RESULTS:
The model animals revealed multiple organ failure and died 6-12 h after the injection of S. aureus. The plasma levels of TSST-1, but not of lipopolysaccharide (LPS), significantly (p < 0.01) and inversely correlated with mean arterial pressure (r = -0.63). Plasma TSST-1 level was significantly reduced and shock-onset time was significantly retarded in the SAAD treated group, although the survival time was not significantly affected.
CONCLUSIONS:
The animal model developed could serve as a model for sepsis. It is suggested that there is the potential application of SAAD in treating superantigen-related sepsis.
AuthorsMayumi Fukuyama, Keishi Miwa, Naoko Shibayama, Shinji Ogura, Takashi Nishiyama, Nobuhiro Maekawa
JournalBlood purification (Blood Purif) Vol. 23 Issue 2 Pg. 119-27 ( 2005) ISSN: 0253-5068 [Print] Switzerland
PMID15640604 (Publication Type: Journal Article)
Chemical References
  • Bacterial Toxins
  • Enterotoxins
  • Lipopolysaccharides
  • Superantigens
  • enterotoxin F, Staphylococcal
Topics
  • Adsorption
  • Animals
  • Bacterial Infections
  • Bacterial Toxins (blood)
  • Blood Pressure
  • Disease Models, Animal
  • Enterotoxins (blood)
  • Hemoperfusion (methods)
  • Lipopolysaccharides (blood)
  • Male
  • Rabbits
  • Sepsis (therapy)
  • Staphylococcus aureus
  • Superantigens (blood, isolation & purification)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: